249 related articles for article (PubMed ID: 28855665)
1. Enhanced antitumor effect on intrapulmonary tumors of docetaxel lung-targeted liposomes in a rabbit model of VX2 orthotopic lung cancer.
Wang L; Li R; Che K; Liu Z; Xiang S; Li M; Yu Y
Sci Rep; 2017 Aug; 7(1):10069. PubMed ID: 28855665
[TBL] [Abstract][Full Text] [Related]
2. Development of docetaxel liposome surface modified with CD133 aptamers for lung cancer targeting.
Ma J; Zhuang H; Zhuang Z; Lu Y; Xia R; Gan L; Wu Y
Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1864-1871. PubMed ID: 29082764
[TBL] [Abstract][Full Text] [Related]
3. Liposomes co-Loaded with 6-Phosphofructo-2-Kinase/Fructose-2, 6-Biphosphatase 3 (PFKFB3) shRNA Plasmid and Docetaxel for the Treatment of non-small Cell Lung Cancer.
Chowdhury N; Vhora I; Patel K; Doddapaneni R; Mondal A; Singh M
Pharm Res; 2017 Nov; 34(11):2371-2384. PubMed ID: 28875330
[TBL] [Abstract][Full Text] [Related]
4. Improved antitumor efficacy and reduced toxicity of docetaxel using anacardic acid functionalized stealth liposomes.
Kushwah V; Jain DK; Agrawal AK; Jain S
Colloids Surf B Biointerfaces; 2018 Dec; 172():213-223. PubMed ID: 30172202
[TBL] [Abstract][Full Text] [Related]
5. Combined integrin α
Qi N; Zhang S; Zhou X; Duan W; Gao D; Feng J; Li A
J Nanobiotechnology; 2021 Dec; 19(1):446. PubMed ID: 34949198
[TBL] [Abstract][Full Text] [Related]
6. α
Zou Y; Sun Y; Guo B; Wei Y; Xia Y; Huangfu Z; Meng F; van Hest JCM; Yuan J; Zhong Z
ACS Appl Mater Interfaces; 2020 Apr; 12(13):14905-14913. PubMed ID: 32148016
[TBL] [Abstract][Full Text] [Related]
7. Docetaxel-loaded exosomes for targeting non-small cell lung cancer: preparation and evaluation
Wang Y; Guo M; Lin D; Liang D; Zhao L; Zhao R; Wang Y
Drug Deliv; 2021 Dec; 28(1):1510-1523. PubMed ID: 34263685
[TBL] [Abstract][Full Text] [Related]
8. Enhanced docetaxel delivery using sterically stabilized RIPL peptide-conjugated nanostructured lipid carriers: In vitro and in vivo antitumor efficacy against SKOV3 ovarian cancer cells.
Kim CH; Kang TH; Kim BD; Lee TH; Yoon HY; Goo YT; Choi YS; Kang MJ; Choi YW
Int J Pharm; 2020 Jun; 583():119393. PubMed ID: 32376445
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of raloxifene-targeted poly(styrene maleic acid)-poly (amide-ether-ester-imide) co-polymeric nanomicelles loaded with docetaxel in breast cancer-bearing mice.
Enteshari S; Varshosaz J; Minayian M; Hassanzadeh F
Invest New Drugs; 2018 Apr; 36(2):206-216. PubMed ID: 29177974
[TBL] [Abstract][Full Text] [Related]
10. Liposome-based co-delivery of siRNA and docetaxel for the synergistic treatment of lung cancer.
Qu MH; Zeng RF; Fang S; Dai QS; Li HP; Long JT
Int J Pharm; 2014 Oct; 474(1-2):112-22. PubMed ID: 25138252
[TBL] [Abstract][Full Text] [Related]
11. Exploring the Promising Potential of High Permeation Vesicle-Mediated Localized Transdermal Delivery of Docetaxel in Breast Cancer To Overcome the Limitations of Systemic Chemotherapy.
Bathara M; Date T; Chaudhari D; Ghadi R; Kuche K; Jain S
Mol Pharm; 2020 Jul; 17(7):2473-2486. PubMed ID: 32496783
[TBL] [Abstract][Full Text] [Related]
12. Docetaxel prodrug liposomes for tumor therapy: characterization, in vitro and in vivo evaluation.
Ren G; Liu D; Guo W; Wang M; Wu C; Guo M; Ai X; Wang Y; He Z
Drug Deliv; 2016 May; 23(4):1272-81. PubMed ID: 26965023
[TBL] [Abstract][Full Text] [Related]
13. Synergistic Antitumor Activity of SH003 and Docetaxel via EGFR Signaling Inhibition in Non-Small Cell Lung Cancer.
Jeong MS; Lee KW; Choi YJ; Kim YG; Hwang HH; Lee SY; Jung SE; Park SA; Lee JH; Joo YJ; Cho SG; Ko SG
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445110
[TBL] [Abstract][Full Text] [Related]
14. Metabolic profile of lung-targeted docetaxel liposomes in rabbits, rats and mice.
Li M; Wang L; Li R; Zhang L; Wang J; Yu Y
Xenobiotica; 2020 Feb; 50(2):125-134. PubMed ID: 30865477
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronic acid coated PLGA nanoparticulate docetaxel effectively targets and suppresses orthotopic human lung cancer.
Wu J; Deng C; Meng F; Zhang J; Sun H; Zhong Z
J Control Release; 2017 Aug; 259():76-82. PubMed ID: 28027947
[TBL] [Abstract][Full Text] [Related]
16. Inhalable dry powder prepared from folic acid-conjugated docetaxel liposomes alters pharmacodynamic and pharmacokinetic properties relevant to lung cancer chemotherapy.
Zhu X; Kong Y; Liu Q; Lu Y; Xing H; Lu X; Yang Y; Xu J; Li N; Zhao D; Chen X; Lu Y
Pulm Pharmacol Ther; 2019 Apr; 55():50-61. PubMed ID: 30738974
[TBL] [Abstract][Full Text] [Related]
17. Anti-tumor activity of high-dose EGFR tyrosine kinase inhibitor and sequential docetaxel in wild type EGFR non-small cell lung cancer cell nude mouse xenografts.
Tang N; Zhang Q; Fang S; Han X; Wang Z
Oncotarget; 2017 Feb; 8(6):9134-9143. PubMed ID: 27852073
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and
Varshosaz J; Enteshari S; Hassanzadeh F; Hashemi-Beni B; Minaiyan M; Sadeghian-Rizi S
Anticancer Agents Med Chem; 2018; 18(14):2017-2031. PubMed ID: 30205803
[TBL] [Abstract][Full Text] [Related]
19. [Preparation of docetaxel-loaded nanomicelles and their anti-Lewis lung cancer effect in vitro].
Wang YJ; Wang J; Hao DL; Yue QX; Xie R; DE GJ; Yi H; Zang C; Zhao QH; Chen YJ
Zhongguo Zhong Yao Za Zhi; 2019 Jun; 44(11):2251-2259. PubMed ID: 31359650
[TBL] [Abstract][Full Text] [Related]
20. Antitumor Effects of Docetaxel in Truncated Basic Fibroblast Growth Factor- Functionalized Liposomes Delivered by d-α-tocopheryl Polyethylene Glycol 2000 Succinate.
Wen J; Wang Z; Qiu N; Liu H; Shu X; Zhu Z; Bai P; Yang L; Chen L
Curr Pharm Des; 2020; 26(34):4338-4348. PubMed ID: 32324508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
